Fundraising Fox

EndoGastric Solutions

San Mateo, US · Delaware corporation · 4 known investors

endogastricsolutions.com ↗

EndoGastric Solutions develops the EsophyX device for transoral incisionless fundoplication (TIF), a minimally invasive endoscopic procedure used to treat gastroesophageal reflux disease (GERD). The company provides reimbursement support and technical assistance to medical practices performing the procedure.

BiotechMedical Devicesin /merit-medical-systems-inc@meritmedical

Founders & leadership

MC
Michael CarusiDirector
SW
Scott WardDirector
AM
Arda MinocherhomjeeDirector
PM
Philip MacdonaldExecutive Officer
BA
Brent AhrensDirector
JD
Jordan DavisDirector
LW
Lee Wrubel, M.D.Director
LB
Louis BaldinoExecutive Officer, Director

Investors · 4

Canaan PartnersStamford · $500K – $20Mvia Brent Ahrens · board
Evidity Health CapitalNew York · $5M
Lightstone VenturesPortola Valley
VCFA GroupNew York · $150K – $2.5M

Reported raises · per SEC filings

Form D private placements
▶$27MraisedDec 2021 · 32 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Louis BaldinoExecutive Officer, Director
  • Darren CrowExecutive Officer
  • Michael CarusiDirector
  • Theodore StephensExecutive Officer
  • Brent AhrensDirector
  • Alejandro SanchezDirector
  • John GillingsDirector
  • Michael BurkeExecutive Officer
  • Kunal PaymasterDirector
  • Martin ReidExecutive Officer
Offering amount
$45M
Amount sold
$27M
First sale
Nov 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40.6MraisedJun 2019 · 31 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Arda MinocherhomjeeDirector
  • Uri GeigerDirector
  • Theodore StephensExecutive Officer
  • Martin ReidExecutive Officer
  • Darren CrowExecutive Officer
  • Michael BurkeExecutive Officer
  • Louis BaldinoExecutive Officer, Director
  • Philip MacdonaldExecutive Officer
  • Jordan DavisDirector
  • Brent AhrensDirector
  • Kunal PaymasterDirector
  • Alejandro SanchezDirector
  • Michael CarusiDirector
Offering amount
$40.6M
Amount sold
$40.6M
First sale
Jun 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedMay 2015 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael CarusiDirector
  • Scott WardDirector
  • Arda MinocherhomjeeDirector
  • Philip MacdonaldExecutive Officer
  • Brent AhrensDirector
  • Jordan DavisDirector
  • Lee Wrubel, M.D.Director
  • Louis BaldinoExecutive Officer, Director
Offering amount
$25M
Amount sold
$10M
First sale
May 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedApr 2015 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael CarusiDirector
  • Scott WardDirector
  • Skip BaldinoExecutive Officer, Director
  • Arda MinocherhomjeeDirector
  • Jordan DavisDirector
  • Brent AhrensDirector
  • Philip MacdonaldExecutive Officer
  • Lee Wrubel, M.D.Director
Offering amount
$1.5M
Amount sold
$1.3M
Minimum investment
$1.8K
First sale
Apr 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.